Dutch biotech firm Vico Therapeutics gathers $31m Series A

Vico Therapeutics, a Dutch biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, has raised $31 million in Series A financing.

ByIris Dorbian

29 July 2020•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Healthcare Briefs

Dutch biotech firm Vico Therapeutics gathers $31m Series A

Kurma Partners

Polaris Partners

Pontifax

Pureos Bioventures

Related articles